Video: Andreas Chrysostomou discusses the new AICPA Accounting and Valuation Guide: Assets Acquired to be Used in Research and Development

Duff & Phelps Managing Director and Healthcare and Life Sciences industry leader Andreas Chrysostomou discusses some of the highlights of the new AICPA Accounting and Valuation Guide on IPR&D. Discussion topics include the risks of not valuing IPR&D properly, the now permissible relief from royalty method, treatment of consideration and milestone payments, and acceptable approaches for selecting the appropriate discount rate. 

Watch the video